Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:BTEC

Principal Healthcare Innovators ETF (BTEC) Price, Holdings, & News

Principal Healthcare Innovators ETF logo

About Principal Healthcare Innovators ETF (NASDAQ:BTEC)

Key Stats

Today's Range
$39.49
$39.49
50-Day Range
$35.83
$41.10
52-Week Range
$25.66
$41.10
Volume
N/A
Average Volume
7,863 shs
Market Capitalization
$16.19 million
Assets Under Management
$16.16 million
Dividend Yield
1.14%
Net Expense Ratio
0.42%
Aggregate Rating
Buy

ETF Overview

The Principal Healthcare Innovators ETF (BTEC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to hold equities of small- and mid-cap healthcare firms in the US. The fund uses a proprietary, quantitative model to construct the portfolio. BTEC was launched on Aug 19, 2016 and is managed by Principal.

Principal Healthcare Innovators ETF Expenses

TypeBTECHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.42%0.57%0.55%0.50%0.52%
Other Expenses0.00%0.30%0.49%0.41%0.53%
Total Expense0.42%0.70%0.71%0.64%0.71%
Fee Waiver0.00%-0.45%-0.51%-0.31%-0.56%
Net Expense0.42%0.61%0.61%0.57%0.59%
Receive BTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Principal Healthcare Innovators ETF and its competitors with MarketBeat's FREE daily newsletter.

BTEC ETF News Headlines

BioNTech (BNTX) Presents at Innovation Series: AI Day
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More Headlines

BTEC ETF - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Principal Healthcare Innovators ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Micron Technology (MU), Quest Diagnostics (DGX), Dynavax Technologies (DVAX), iShares Biotechnology ETF (IBB) and Novavax (NVAX).

Fund Details

Issuer
Principal
Fund Name
Principal Healthcare Innovators ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:BTEC
Inception Date
8/19/2016
Fund Manager
Jeffrey A. Schwarte, Aaron J. Siebel
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
5

Fund Statistics

Assets Under Management
$16.16 million
Average Daily Volume
$703.80
Discount/Premium
0.08%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
Principal Global Investors, LLC
Custodian
State Street Bank and Trust Company
Distributor
ALPS Distributors, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
1,500 shs

Miscellaneous

Beta
1.01
Creation Unit
50,000
Creation Fee
$600.00
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Top 5 BTEC Holdings

  • Us Dollar
    Holding Weight: 99.89%
  • Scilex (NASDAQ:SCLX)
    Holding Weight: 0.09%
  • Contra Chinook Therape Common Stock
    Holding Weight: 0.02%
  • Omniab
    Holding Weight: 0.00%
  • Omniab
    Holding Weight: 0.00%

This page (NASDAQ:BTEC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners